Table 2.
Characteristic | Without overexpression of miRNA 141 (n=15) | With overexpression of miRNA 141 (n=4) | Total (n=19) | p-value |
---|---|---|---|---|
Male sex | 12 (80.0) | 4 (100.0) | 16 (84.2) | >0.99 |
Age, yr | 71 (52–78) | 66 (55–85) | 71 (52–85) | 0.993 |
Malignancy | 0.603 | |||
Perihilar | 5 (33.3) | 2 (50.0) | 7 (36.8) | |
Distal | 10 (66.7) | 2 (50.0) | 12 (63.2) | |
Stage | >0.99 | |||
I | 2 (13.3) | 0 | 2 (10.5) | |
II | 11 (73.3) | 3 (75.0) | 14 (73.7) | |
III | 2 (13.3) | 1 (25.0) | 3 (15.8) | |
Differentiation | >0.99 | |||
Well | 3 (20.0) | 0 | 3 (15.8) | |
Moderately | 8 (53.3) | 3 (75.0) | 11 (57.9) | |
Poorly | 4 (26.7) | 1 (25.0) | 5 (26.3) | |
Invasion | ||||
Angiolymphatic | 3 (20.0) | 4 (100.0) | 7 (36.8) | 0.009 |
Venous | 1 (6.7) | 1 (25.0) | 2 (10.5) | 0.386 |
Perineural | 13 (86.7) | 4 (100.0) | 17 (89.5) | >0.99 |
Data are presented as number (%) or median (range).
miRNA, micro-ribonucleic acid.